To the editor: Fanconi anemia (FA) is a rare, phenotypically heterogeneous inherited disorder clinically characterized by congenital abnormalities, progressive bone marrow failure (BMF), and a predisposition to develop malignancies.[1][1] Hematopoietic stem cell transplantation (HSCT) is the only
No takes yet. Share an insight, caveat, or question.
Benajiba et al. (2015) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: